The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106535675 10653567 5 F 20140513 20160623 20141216 20160630 EXP US-THROMBOGENICS INC-CLI-2014-1057 THROMBOGENICS 80.32 YR F Y 0.00000 20160630 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106535675 10653567 1 PS JETREA OCRIPLASMIN 1 Intraocular 0.125 MG, ONE TIME DOSE 125422 .125 MG SOLUTION FOR INJECTION
106535675 10653567 2 C HYZAAR 50/125 2 Oral 1 TAB, QD U 0 1 DF
106535675 10653567 3 C ZEBETA BISOPROLOL FUMARATE 1 Oral 5 MG, QD U 0 5 MG
106535675 10653567 4 C CALCIUM CALCIUM 1 Oral 1 TAB, QD U 0 1 DF
106535675 10653567 5 C VITAMIN D /00107901/ ERGOCALCIFEROL 1 Oral 1 TAB, QD U 0 1 DF
106535675 10653567 6 C ASPIRIN. ASPIRIN 1 Oral 81 MG, QD U 0 81 MG
106535675 10653567 7 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 1 PUFF, QD U 0
106535675 10653567 8 C MIRAPEX PRAMIPEXOLE DIHYDROCHLORIDE 1 Oral 15 MG, QD U 0 15 MG
106535675 10653567 9 C FENOFIBRATE. FENOFIBRATE 1 Oral 134 MG, QD U 0 134 MG
106535675 10653567 10 C MELOXICAM. MELOXICAM 1 Oral 15 MG, QD U 0 15 MG
106535675 10653567 11 C TEMAZEPAM. TEMAZEPAM 1 Oral 15 MG, QD U 0 15 MG
106535675 10653567 12 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 40 MG, QD U 0 40 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106535675 10653567 1 Vitreous adhesions
106535675 10653567 2 Hypertension
106535675 10653567 3 Hypertension
106535675 10653567 4 Medical diet
106535675 10653567 5 Medical diet
106535675 10653567 6 Cerebrovascular accident prophylaxis
106535675 10653567 7 Productive cough
106535675 10653567 8 Parkinson's disease
106535675 10653567 9 Hypercholesterolaemia
106535675 10653567 10 Osteoarthritis
106535675 10653567 11 Insomnia
106535675 10653567 12 Dyspepsia

Outcome of event

Event ID CASEID OUTC COD
106535675 10653567 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
106535675 10653567 Chromatopsia
106535675 10653567 Photopsia
106535675 10653567 Pupillary reflex impaired
106535675 10653567 Vision blurred
106535675 10653567 Visual impairment
106535675 10653567 Vitreous floaters

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106535675 10653567 1 20140512 20140512 0
106535675 10653567 2 2007 0
106535675 10653567 3 2007 0
106535675 10653567 4 2013 0
106535675 10653567 5 2007 0
106535675 10653567 6 2013 0
106535675 10653567 7 2010 0
106535675 10653567 8 2009 0
106535675 10653567 9 2004 0
106535675 10653567 10 2012 0
106535675 10653567 11 1999 0
106535675 10653567 12 2012 0